PMC:7195088 / 31130-31393 JSONTXT

Annnotations TAB JSON ListView MergeView

{"target":"https://pubannotation.org/docs/sourcedb/PMC/sourceid/7195088","sourcedb":"PMC","sourceid":"7195088","source_url":"https://www.ncbi.nlm.nih.gov/pmc/7195088","text":"Humanized monoclonal IgG1 antibody, tocilizumab inhibits both membrane-bound and soluble IL-6 receptors. IL-6, is one of the main drivers of immunologic response and symptoms in patients with dysregulated cytokine release that has been observed in severe COVID-19","tracks":[{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T34","span":{"begin":26,"end":34},"obj":"Body_part"},{"id":"T35","span":{"begin":89,"end":91},"obj":"Body_part"},{"id":"T36","span":{"begin":105,"end":107},"obj":"Body_part"},{"id":"T37","span":{"begin":205,"end":213},"obj":"Body_part"}],"attributes":[{"id":"A34","pred":"fma_id","subj":"T34","obj":"http://purl.org/sig/ont/fma/fma62871"},{"id":"A35","pred":"fma_id","subj":"T35","obj":"http://purl.org/sig/ont/fma/fma86578"},{"id":"A36","pred":"fma_id","subj":"T36","obj":"http://purl.org/sig/ont/fma/fma86578"},{"id":"A37","pred":"fma_id","subj":"T37","obj":"http://purl.org/sig/ont/fma/fma84050"},{"subj":"T34","pred":"source","obj":"LitCovid-PD-FMA-UBERON"},{"subj":"T35","pred":"source","obj":"LitCovid-PD-FMA-UBERON"},{"subj":"T36","pred":"source","obj":"LitCovid-PD-FMA-UBERON"},{"subj":"T37","pred":"source","obj":"LitCovid-PD-FMA-UBERON"}]},{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T161","span":{"begin":255,"end":263},"obj":"Disease"}],"attributes":[{"id":"A161","pred":"mondo_id","subj":"T161","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"subj":"T161","pred":"source","obj":"LitCovid-PD-MONDO"}]},{"project":"LitCovid-PD-CLO","denotations":[{"id":"T172","span":{"begin":0,"end":9},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_9606"},{"id":"T173","span":{"begin":62,"end":70},"obj":"http://purl.obolibrary.org/obo/UBERON_0000158"},{"id":"T174","span":{"begin":227,"end":230},"obj":"http://purl.obolibrary.org/obo/CLO_0051582"}],"attributes":[{"subj":"T172","pred":"source","obj":"LitCovid-PD-CLO"},{"subj":"T173","pred":"source","obj":"LitCovid-PD-CLO"},{"subj":"T174","pred":"source","obj":"LitCovid-PD-CLO"}]},{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T418","span":{"begin":36,"end":47},"obj":"Chemical"},{"id":"T419","span":{"begin":89,"end":91},"obj":"Chemical"},{"id":"T421","span":{"begin":105,"end":107},"obj":"Chemical"}],"attributes":[{"id":"A418","pred":"chebi_id","subj":"T418","obj":"http://purl.obolibrary.org/obo/CHEBI_64360"},{"id":"A419","pred":"chebi_id","subj":"T419","obj":"http://purl.obolibrary.org/obo/CHEBI_63895"},{"id":"A420","pred":"chebi_id","subj":"T419","obj":"http://purl.obolibrary.org/obo/CHEBI_74072"},{"id":"A421","pred":"chebi_id","subj":"T421","obj":"http://purl.obolibrary.org/obo/CHEBI_63895"},{"id":"A422","pred":"chebi_id","subj":"T421","obj":"http://purl.obolibrary.org/obo/CHEBI_74072"},{"subj":"T418","pred":"source","obj":"LitCovid-PD-CHEBI"},{"subj":"T419","pred":"source","obj":"LitCovid-PD-CHEBI"},{"subj":"T421","pred":"source","obj":"LitCovid-PD-CHEBI"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"LitCovid-PD-FMA-UBERON","color":"#93a9ec","default":true},{"id":"LitCovid-PD-MONDO","color":"#c3ec93"},{"id":"LitCovid-PD-CLO","color":"#ec93dd"},{"id":"LitCovid-PD-CHEBI","color":"#93ece1"}]}]}}